Drug boosts mitochondria in immune cells, extends worm lifespan

K21 is a compound that fights bacteria, viruses, and fungi. Researchers already knew it promotes wound healing, but the mechanism was unclear. The researchers now found that K21 reprogrammes macrophages (immune cells that clear infections and damaged tissue). It activates mitophagy: the process by which cells break down and replace damaged mitochondria (the energy-producing organelles of the cell).

This matters because mitochondrial quality control is one of the best-established mechanisms for slowing aging in animal models. The better mitochondria function, the better cells produce energy and resist stress.

Extended lifespan in roundworms

The researchers also tested K21 in the model organism C. elegans, a microscopic roundworm widely used in aging research. Worms treated with K21 lived longer. They showed no adverse effects on growth or fertility. The compound also altered the expression of genes involved in energy metabolism.

This is a promising result, but the translation to humans is far from certain. C. elegans lacks blood, organs, and the complex biology of mammals. The fact that the effect was also observed in human macrophages adds some relevance. But this remains laboratory research.

Immunity and aging as linked systems

What makes this research relevant to longevity science is the connection it draws between immune function and mitochondrial health. Macrophages are not only defenders against infection. They also clear aged and damaged tissue. If their mitochondria function better, so do they. And if macrophage function improves, that could in principle affect how quickly tissue ages.

The research was published in Life Science Alliance. It opens a new direction: repurposing existing antimicrobial compounds as potential tools for cellular health.

Read the original article